Account
Inquiry
Tirzepatide, also known as LY3298176, is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It is primarily developed for research into type 2 diabetes treatment. With a molecular formula of C225H348N48O68 and a molecular weight of 4813, this peptide exhibits high affinity for GIP and GLP-1 receptors, contributing to its efficacy in glucose control and potential weight loss applications.
Research indicates that Tirzepatide demonstrates superior performance compared to selective GLP-1 receptor agonists like Dulaglutide. Its mechanism involves mimicking natural GIP actions, which supports investigations into hyperglycemia reduction. The peptide features a lys side chain with PEG modification, enhancing water solubility and functional properties for experimental use.
Clinical stage studies, such as the SURMOUNT-1 trial, have highlighted Tirzepatide's potential in weight management, with average weight reductions observed over 72 weeks. This makes it a valuable compound for scientific research focused on obesity and related metabolic conditions. It is important to note that this product is strictly for research purposes and not intended for personal use.
Our Tirzepatide is supplied as a white powder with a purity of 99.9%, ensuring consistency and reliability for laboratory applications. It is packaged in vials, with options for custom labeling to meet specific research requirements. Proper storage guidelines include keeping the peptide in a cold, dry, and dark environment to maintain stability.
